Amoxicillin/clavulanic acid

ApprovedSmall molecule

Lundbeck

Amoxicillin/clavulanic acid is one of 110 small molecule programs targeting Pneumonia. It is currently in Approved.

Indications

Total Trials

Active Trials

109

Competitors

Pipeline

Status by Indication[3][1]

Indication

PneumoniaActive, not recruiting

Pulmonary TuberculosisActive, not recruiting

DiverticulitisActive, not recruiting

TuberculosisActive, not recruiting

PneumoniaPhase 2/Phase 3

Active, not recruiting

Pulmonary TuberculosisPhase 2

Active, not recruiting

DiverticulitisApproved

Active, not recruiting

TuberculosisPhase 1

Active, not recruiting

Competition

Competitive Landscape

547 competitors in Pneumonia

#DrugCompanyPhaseTrials

Amoxicillin/clavulanic acid

Lundbeck

Approved

1 2

Jakafi

Incyte

Preclinical

1 3

Primaquine

Sanofi

Preclinical

1 4

Acanya

Pfizer

Preclinical

1 5

Innohep

Alnylam Pharmaceuticals

Preclinical

1 6

Avlosulfon

AAlmirall, S.A.

Preclinical

4 7

Virazole

CConrado Roberto Hoffmann Filho

Preclinical

2 8

Advil

KKenvue Brands

Preclinical

2 9

Gantanol

CConrado Roberto Hoffmann Filho

Preclinical

2 10

Tagamet

DDT MedTech, LLC

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Adult1 trial

A Trial Investigating Lu AF28996 in Healthy Adult Participants

Completed· Lundbeck logo

Lundbeck·Phase 1·NCT06277609·22 enrolled

Pulmonary Tuberculosis1 trial

Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers

Completed·NNational University Hospital, Singapore·Phase 2·NCT02381470·58 enrolled

Surgical Site Infections1 trial

Benefit of a Single Preoperative Dose of Antibiotics for the Prevention of Surgical Site Infections

Completed·SSwiss Tropical & Public Health Institute·N/A·NCT00801099·276 enrolled

Diverticulitis1 trial

Randomized Clinical Trial to Compare the Treatment of Mild Acute Diverticulitis With or Without Antibiotics

Completed·CCorporacion Parc Tauli·Phase 4·NCT02785549·480 enrolled

Antibiotic Prophylaxis1 trial

Duration of Postoperative Antibiotic Prophylaxis in Facial Fractures

Terminated·IInsel Gruppe AG, University Hospital Bern·Phase 4·NCT01583062·217 enrolled

2 more indications

Pneumonia1 trial

Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia

Unknown status·RRadboud University Medical Center·Phase 2/3·NCT01598402·106 enrolled

Tuberculosis1 trial

Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers

Completed·NNational University Hospital, Singapore·Phase 1·NCT02393586·43 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Amoxicillin/clavulanic acid. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Amoxicillin/clavulanic acid compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Amoxicillin/clavulanic acid. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Lundbeck company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: Lundbeck

Amoxicillin/clavulanic acid

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Adult1 trial

Pulmonary Tuberculosis1 trial

Surgical Site Infections1 trial

Diverticulitis1 trial

Antibiotic Prophylaxis1 trial

Pneumonia1 trial

Tuberculosis1 trial

References

Drug Info

Quick Facts

Related News